Search research articles
Contact Us
Filters
Showing results (1-10 of 30) with videos related to
Page
of 3
Sort By:
Nature Biotechnology
|
December 14, 2011
Dissecting cancer heterogeneity
David Dornan, Jeff Settleman
Oncoimmunology
|
June 22, 2012
To respond or not to respond to CD40 agonism: That is the prediction
Xiaoyan Shi, David Dornan
Current Biology : CB
|
September 28, 2010
Cancer: miRNA addiction - depending on life's little things
David Dornan, Jeff Settleman
The Journal of Biological Chemistry
|
December 25, 2002
DNA-dependent acetylation of p53 by the transcription coactivator p300
David Dornan, Harumi Shimizu, Neil D Perkins, et al.
Oncogene
|
November 7, 2002
Regulation of the IRF-1 tumour modifier during the response to genotoxic stress involves an ATM-dependent signalling pathway
Jessica Pamment, Eleanor Ramsay, Michael Kelleher, et al.
Molecular and Cellular Biology
|
November 13, 2003
The proline repeat domain of p53 binds directly to the transcriptional coactivator p300 and allosterically controls DNA-dependent acetylation of p53
David Dornan, Harumi Shimizu, Lindsay Burch, et al.
Molecular and Cellular Biology
|
October 29, 2004
Interferon regulatory factor 1 binding to p300 stimulates DNA-dependent acetylation of p53
David Dornan, Mirjam Eckert, Maura Wallace, et al.
BMC Cancer
|
October 29, 2010
Statistical techniques to construct assays for identifying likely responders to a treatment under evaluation from cell line genomic data
Erich P Huang, Jane Fridlyand, Nicholas Lewin-Koh, et al.
Science (New York, N.Y.)
|
August 26, 2006
ATM engages autodegradation of the E3 ubiquitin ligase COP1 after DNA damage
David Dornan, Harumi Shimizu, Angie Mah, et al.
Science (New York, N.Y.)
|
January 24, 2004
Human De-etiolated-1 regulates c-Jun by assembling a CUL4A ubiquitin ligase
Ingrid E Wertz, Karen M O'Rourke, Zemin Zhang, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 30) with videos related to
Sort By:
Page
of 3
Nature Biotechnology
|
December 14, 2011
Dissecting cancer heterogeneity
David Dornan, Jeff Settleman
Oncoimmunology
|
June 22, 2012
To respond or not to respond to CD40 agonism: That is the prediction
Xiaoyan Shi, David Dornan
Current Biology : CB
|
September 28, 2010
Cancer: miRNA addiction - depending on life's little things
David Dornan, Jeff Settleman
The Journal of Biological Chemistry
|
December 25, 2002
DNA-dependent acetylation of p53 by the transcription coactivator p300
David Dornan, Harumi Shimizu, Neil D Perkins, et al.
Oncogene
|
November 7, 2002
Regulation of the IRF-1 tumour modifier during the response to genotoxic stress involves an ATM-dependent signalling pathway
Jessica Pamment, Eleanor Ramsay, Michael Kelleher, et al.
Molecular and Cellular Biology
|
November 13, 2003
The proline repeat domain of p53 binds directly to the transcriptional coactivator p300 and allosterically controls DNA-dependent acetylation of p53
David Dornan, Harumi Shimizu, Lindsay Burch, et al.
Molecular and Cellular Biology
|
October 29, 2004
Interferon regulatory factor 1 binding to p300 stimulates DNA-dependent acetylation of p53
David Dornan, Mirjam Eckert, Maura Wallace, et al.
BMC Cancer
|
October 29, 2010
Statistical techniques to construct assays for identifying likely responders to a treatment under evaluation from cell line genomic data
Erich P Huang, Jane Fridlyand, Nicholas Lewin-Koh, et al.
Science (New York, N.Y.)
|
August 26, 2006
ATM engages autodegradation of the E3 ubiquitin ligase COP1 after DNA damage
David Dornan, Harumi Shimizu, Angie Mah, et al.
Science (New York, N.Y.)
|
January 24, 2004
Human De-etiolated-1 regulates c-Jun by assembling a CUL4A ubiquitin ligase
Ingrid E Wertz, Karen M O'Rourke, Zemin Zhang, et al.
Page
of 3